Have a personal or library account? Click to login
Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties Cover

Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties

Open Access
|Feb 2017

References

  1. 1. A. M. Stuckey, Breast cancer: epidemiology and risk factors, Clin. Obst. Gynecol. 54 (2011) 96-102; DOI: 10.1097/GRF.0b013e3182080056.10.1097/GRF.0b013e3182080056
  2. 2. F. C. Thorn, C. Oshiro, S. Marsh, T. Hernandez-Boussard, H. McLeod, T. Klein and B. R. Altman, Doxorubicin pathways: pharmacodynamics and adverse effects, Pharmacogenet. Genom. 21 (2011) 440-446; DOI: 10.1097/FPC.0b013e32833ffb56.10.1097/FPC.0b013e32833ffb56
  3. 3. A. Jashari, F. Imeri, L. Ballazhi, A. Shabani, B. Mikhova, G. Dräger, E. Popovski and A. Huwiler, Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinyldiene-chroman-2,4-diones on cancer and non-cancer cell growth and death, Bioorg. Med. Chem. 22 (2014) 2655-2661; DOI: 10.1016/j.bmc.2014.03.026.10.1016/j.bmc.2014.03.026
  4. 4. S. Chen, M. Cho, K. Karlsberg, D. Zhou and Y. Yuan, Biochemical and biological characterization of a novel anti-aromatase coumarin derivative, J. Biol. Chem. 279 (2004) 48071-48078; DOI: 10.1074/ jbc.M406847200.10.1074/jbc.M406847200
  5. 5. L. Woo, A. Purohit, B. Malini, M. Reed and B. Potter, Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates, Chem. Biol. 7 (2000) 773-791; DOI: 10.1016/S1074-5521(00)00023-5.10.1016/S1074-5521(00)00023-5
  6. 6. M. Musa, J. Cooperwood and M. Khan, A review of coumarin derivatives in pharmacotherapy of breast cancer, Curr. Med. Chem. 15 (2008) 2664-2679; DOI: 10.2174/092986708786242877.10.2174/092986708786242877377264418991629
  7. 7. S. Kirkiacharian, A. Lormier, H. Chidiack, F. Bouchoux and E. Cérède, Synthesis and binding affinity to human alpha and beta estrogen receptors of various 7-hydroxycoumarins substituted at 4- and 3,4- positions, Farmaco 59 (2004) 981-986; DOI: 10.1016/j.farmac.2004.08.004.10.1016/j.farmac.2004.08.00415598433
  8. 8. M. Halasi, H. Zhao, H. Dahari, U. G. Bhat, E. B. Gonzalez, A. V. Lyubimo, D. A. Tonetti and A. L. Gartel, Thiazole antibiotics against breast cancer, Cell Cycle 9 (2010) 1214-1217; DOI: 10.4161/ cc.9.6.10955.10.4161/cc.9.6.1095520410687
  9. 9. J. Shaw, B. Chen, J. P. Bourgault, H. Jiang, K. Narendra, M. Jayshree, A. V. Frederick, M. Joe, B. Kevin, P. Halina, E. Matthew and R. A. Peter, Synthesis and biological evaluation of novel nphenyl-5-carboxamidyl isoxazoles as potential chemotherapeutic agents for colon cancer, Am. J. Biomed. Sci. 4 (2012) 14-25; DOI: 10.5099/aj120100014.10.5099/aj120100014418295325285182
  10. 10. P. Poma, M. Notarbartolo, M. Labbozzetta, A. Maurici, V. Carina, A. Alaimo, M. Rizzi, D. Simoni and N. D’Alessandro, The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis, Int. J. Mol. Med. 20 (2007) 329-335; DOI: 10.3892/ ijmm.20.3.329.
  11. 11. L. Ballazhi, E. Popovski, A. Jashari, F. Imeri, I. Ibrahimi, B. Mikhova and K. Mladenovska, Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases, Acta Pharm. 65 (2015) 53-63; DOI: 10.1515/acph-2015-0002.10.1515/acph-2015-000225781704
  12. 12. A. Jashari, E. Popovski, B. Mikhova, P. R. Nikolova and L. B. Shivachev, 3-[2-(5-tert-Butyl-1,2-oxazol-3-yl)hydrazinylidene]chroman-2,4-dione, Acta Crystallogr. E69 (2013) o258; DOI: 10.1107/ S1600536813000858.
  13. 13. L. Ballazhi, F. Imeri, A. Dimovski, A. Jashari, E. Popovski, P. B. Selmani, B. Mikhova, G. Dräger, E. Alili-Idrizi and K. Mladenovska, Synergy of novel coumarin derivatives and tamoxifen in blocking growth and inducing apoptosis of breast cancer cells, Mac. Pharm. Bull. 60 (2014) 35-44.10.33320/maced.pharm.bull.2014.60.01.005
  14. 14. N. C. Bols, V. R. Dayeh, L. E. J. Lee and K. Schirmer, Use of Fish Cell Lines in the Toxicology and Ecotoxicology of Fish, in Biochemistry and Molecular Biology of Fishes - Environmental Toxicology (Eds. T. P. Mommsen and T. W. Moon), Vol. 6, Elsevier Science, Amsterdam 2005, pp. 43-84.10.1016/S1873-0140(05)80005-0
  15. 15. R. Hamid, Y. Rotshteyn, L. Rabadi, R. Parikh and P. Bullock, Comparison of alamar blue and MTT assays for high through-put screening, Toxicol. In Vitro 18 (2004) 703-710; DOI: 10.1016/j. tiv.2004.03.012.
  16. 16. W. F. Deckert and K. H. Remmer, In vitro inhibition of rat and human liver microsomal enzymes by 4-hydroxycoumarin anticoagulants and related compounds, Chem. Biol. Inter. 5 (1972) 255-263; DOI: 10.1016/0009-2797(72)90029-4.10.1016/0009-2797(72)90029-4
  17. 17. H. Liu, Y. Wang, A. Sharma, R. Mao, N. Jiang, B. Dun and X. J. She, Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling, Anticancer Drugs 26 (2015) 667-677; DOI: 10.1097/ CAD.0000000000000232.10.1097/CAD.000000000000023225811964
  18. 18. O. Bar-On, M. Shapira and D. D. Hershko, Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells, Anti-Cancer Drugs 18 (2007) 1113-1121; DOI: 10.1097/CAD.0b013e3282ef4571.10.1097/CAD.0b013e3282ef457117893511
  19. 19. R. Lüpertz, W. Wätjen, R. Kahl and Y. Chovolou, Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells, Toxicology 271 (2010) 115-121; DOI: 10.1016/j.tox.2010.03.012.10.1016/j.tox.2010.03.01220346999
  20. 20. A. M. Musa, L. V. Badisa, M. L. Latinwo, J. Cooperwood, A. Sinclair and A. Abdullah, Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines, Anticancer Res. 31 (2011) 2017-2022.
  21. 21. A. Goel, K. A. Prasad, S. V. Parmar, B. Ghosh and N. Saini, 7,8-Dihydroxy-4-methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/MAPK signaling, FEBS Lett. 581 (2007) 2447-2454; DOI: 10.1016/j.febslet.2007.04.052.10.1016/j.febslet.2007.04.05217485089
  22. 22. D. Alesiani, R. Cicconi, M. Mattei, C. Montesano, R. Bei and A. Canini, Cell cycle arrest and differentiation induction by 5,7-dimethoxycoumarin in melanoma cell lines, Int. J. Oncol. 32 (2008) 425-434; DOI: 10.3892/ijo.32.2.425.10.3892/ijo.32.2.425
  23. 23. F. Haghighi, M. M. Matin, A. R. Bahrami, M. Iranshahi, F. B. Rassouli and A. Haghighitalab, The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage, DARU J. Pharm. Sci. 22 (2014) Article ID: 3 (10 pages); DOI: 10.1186/2008-2231-22-3.10.1186/2008-2231-22-3389859824393601
  24. 24. C. Barthomeuf, S. Lim, M. Iranshahi and P. Chollet, Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis, Phytomedicine 15 (2008) 103-111; DOI: 10.1016/j.phymed.2007.04.001.10.1016/j.phymed.2007.04.00117689942
  25. 25. Y. J. Chuang, F. Y. Huang, F. H. Lu, C. H. Ho, S. J. Yang, M. T. Li, W. N. Chang and G. J. Chung, Coumarin induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells through a mitochondria- and caspase-3 dependent mechanism and NF-kappaB down-regulation, In Vivo 21 (2007) 1003-1010.
  26. 26. M. Kielbus, K. Skalicka-Wozniak, A. Grabarska, W. Jeleniewicz, M. Dmoszynska-Graniczka, A. Marston, K. Polberg, P. Gawda, J. Klatka and A. Stepulak, 7-Substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro, Anticancer Res. 33 (2013) 4347-4356.
  27. 27. D. Yang, T. Gu, T. Wang, Q. Tang and C. Ma, Effects of osthole on migration and invasion in breast cancer cells, Biosci. Biotechnol. Biochem. 74 (2010) 1430-1434; DOI: 1271/bbb.100110.10.1271/bbb.100110
  28. 28. W. F. van der Giesen and L. H. Janssen, Influence of ionization and ion-pair formation on lipophilicity of some 4-hydroxy-coumarin derivatives in the octanol-water system, Int. J. Pharm. 12 (1982) 231-249; DOI: 10.1016/0378-5173(82)90122-3.10.1016/0378-5173(82)90122-3
  29. 29. H. Schönherr and T. Cernak, Profound methyl effects in drug discovery and a call for new C-H methylation reactions, Angew. Chem. Int. Ed. Engl. 52 (2013) 12256-12267; DOI: 10.1002/ anie.201303207.10.1002/anie.20130320724151256
  30. 30. S. C. Leung, S. S. Leung, J. R. Tirado and L. W. Jorgensen, Methyl effects on protein-ligand binding, J. Med. Chem. 55 (2012) 4489-4500; DOI: 10.1021/jm3003697. 10.1021/jm3003697335332722500930
DOI: https://doi.org/10.1515/acph-2017-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 35 - 52
Accepted on: Sep 21, 2016
|
Published on: Feb 21, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2017 Lulzime Ballazhi, Faik Imeri, Ahmed Jashari, Emil Popovski, Goran Stojković, Aleksandar J. Dimovski, Bozhana Mikhova, Kristina Mladenovska, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.